Rauscher murine leukemia virus (R-MuLV) and Moloney murine leukemia virus (M-MuLV) belong to a class of replication-competent retroviruses which induce leukemias in newborn mice after prolonged periods of latency and replicate in tissue culture cells without causing transformation. Recently, it has been possible to show that different mouse leukemia viruses show a high degree of specificity in their target cells for transformation. R-MuLV and M-MuLV induce tumors of the B and T lymphoid cells, respectively (16) . The advent of recombinant DNA and nucleotide sequencing techniques has made it possible to study retroviral genomes in a precise biochemical manner. The M-MuLV genome has been molecularly cloned as biologically active DNA (2) . In studies aimed at defining at a molecular level the mechanisms responsible for the different target cell specificities of R-MuLV and M-MuLV, we reasoned that it would be important to obtain molecular clones of R-MuLV. In the present report, we describe the isolation, amplification by recombinant DNA techniques, and initial biological characterization of the integrated form of this virus.
Restriction analysis of unintegrated R-MuLV DNA. Molecular cloning of the R-MuLV genome required knowledge of which restriction enzymes cleaved within the viral genome. Linear unintegrated R-MuLV DNA isolated from the Hirt supernatant (11) of 12 and 15 kbp by using R-MuLV c probe. The EcoRI-digested DNA wa for these fragments by RPC-5 colum tography (27) To establish biochemically that our cloned molecule contained the R-MuLV proviral genome, we compared the restriction digests of the cloned molecule with those of unintegrated linear R-MuLV DNA isolated by the Hirt procedure (data not shown). The R-MuLV-specific fragments were identified by hybridization with R-MuLV-specific cDNA. When restriction enzymes which cleaved at multiple sites were used in this analysis, several internal fragments of the cloned DNA showed the same mobility as those generated with linear, unintegrated R-MuLV DNA. The restriction fragments from the cloned DNA that differed in mobility but hybridized with the R-MuLV cDNA probe were presumed to be located at the termini of the proviral DNA and to contain cellular flanking sequences as well. Long terminal repeats (LTRs) have been 'sis of unin-shown to be a common structural feature of the egrated dR-proviral DNAs of avian and mammalian retrotegantsof R-viruses (12, 19 (Fig. 2 ). WDNA as a Orientation of integrated R-MuLV DNA with Ls enriched respect to genomic viral RNA. The gene order of kn chroma-type C retroviruses is known to be 5'-gag pol isity gradi-env-3' (for a review, see reference 29). It is also fragments known that R-MuLV and M-MuLV have a simii of phage lar genomic structure and code for related struc- (25) . From Biological actiity of doned R-MuLV DNA. To determine whether X-RV-1 DNA was biologically active, we analyzed it by transfection on NIH/ 3T3 cells. As little as 10 ng of DNA insert was able to induce the release of particle-associated reverse transcriptase activity (Table 1) . There was no significant difference in infectivity whether or not the insert had been cleaved from its vector with EcoRI.
R-MuLV is an ecotropic virus which is infectious for NIH/Swiss and BALB/c mouse cells and induces XC plaque formation in both cell lines (18, 23 virus, we performed typing radioimmunoassays for R-MuLV gag gene-coded p12. The RV-1 virus, like the parental R-MuLV, completely displaced labeled R-MuLV p12 in binding limiting anti-R-MuLV p12 serum (Fig. 3 ). In contrast, both viruses demonstrated only partial competition in a typing immunoassay for MMuLV p12 (Fig. 3) . Other viruses, including ecotropic AKR and M-MuLV and xenotropic BALB:virus-2 and NIH-MuLV, demonstrated only limited competition in the R-MuLV p12 assay (data not shown). These results established that the p12 of RV-1 virus is immunologically indistinguishable from that of R-MuLV.
Knowledge of the molecular structure of leukemia viruses has led to insights on how these viruses cause tumors. The viral LTR contains signals for RNA transcription and for RNA capping and adenylation (6, 13, 17, 20, 26) . Several laboratories have recently reported that integration of avian leukosis viruses near the cellular analog of an avian retrovirus onc gene, myc, leads to its transcriptional activation (9, 14, 15) . By this model, the random low-frequency integration of a retrovirus LTR near a cellular gene with transforming potential might lead to its activation as a transforming gene. Whether this model can be generalized to other systems or fully explains tumor induction by avian leukemia viruses awaits further analysis.
As one approach toward investigating the mechanisms by which leukemia viruses induce tumors, we compared the target cells for transformation by different mouse leukemia viruses. These studies revealed evidence for a rather high degree of specificity. Thus, R-MuLV transforms a specific subset of cells within the B lymphoid differentiation pathway, whereas MMuLV transforms cells predominately with the T lymphoid cell series (16) . As determined by heteroduplex analysis under stringent hybridization conditions, their genomes are colinear (S. G. Devare, unpublished data). Restriction mapping provides another means of measuring relationships between respective genes. Comparison of the maps of R-MuLV and M-MuLV indicated no long stretch of extremely well conserved sequences (Fig. 3) . Nonetheless, two enzymes, PvuI and ClaI, cleaved toward the 5' and 3' ends, respectively, of each viral genome at approximately the same positions (Fig. 3) . Preliminary comparison of the nucleotide sequences at these sites revealed marked similarities as well (A. Habara, unpublished data). Thus, it may be possible to utilize these sites in the construction of in vitro recombinants in efforts to localize the regions of each viral genome that are responsible for its target cell specificity. At the same time, such studies may shed additional light on the mechanisms by which these leukemia viruses transform lymphoid cells.
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